(2-015) Comparison of Bamlanivimab/etesevimab and Casirivimab/imdevimab for the Treatment of High-Risk COVID-19 Patients

Monday, December 5, 2022

10:45 AM – 11:45 AM

Location: Bayside A, Level 1

Category: Evaluative Study
Topic: Infectious Diseases/HIV

Co-Author(s): Jihyun Chae, Klaudia Harris, Taylor Watson, Darrell Childress

Primary Author(s)

Diana Doan, PharmD Candidate, 2023
PharmD Candidate 2023
Auburn University Harrison College of Pharmacy, Alabama